HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic Cancer

NCT06217042 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

524

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: HR070803; Oxaliplatin; 5Fluorouracil; Calcium folinate
DRUG: gemcitabine; capecitabine

Sponsor

Fudan University